Loading…
Clinical proteomics: A need to define the field and to begin to set adequate standards
The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinica...
Saved in:
Published in: | Proteomics. Clinical applications 2007-02, Vol.1 (2), p.148-156 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3 |
container_end_page | 156 |
container_issue | 2 |
container_start_page | 148 |
container_title | Proteomics. Clinical applications |
container_volume | 1 |
creator | Mischak, Harald Apweiler, Rolf Banks, Rosamonde E. Conaway, Mark Coon, Joshua Dominiczak, Anna Ehrich, Jochen H. H. Fliser, Danilo Girolami, Mark Hermjakob, Henning Hochstrasser, Denis Jankowski, Joachim Julian, Bruce A. Kolch, Walter Massy, Ziad A. Neusuess, Christian Novak, Jan Peter, Karlheinz Rossing, Kasper Schanstra, Joost Semmes, O. John Theodorescu, Dan Thongboonkerd, Visith Weissinger, Eva M. Van Eyk, Jennifer E. Yamamoto, Tadashi |
description | The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. Our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state‐of‐the‐art, both in diagnosis and in therapy of diseases. |
doi_str_mv | 10.1002/prca.200600771 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_816528484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>816528484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3</originalsourceid><addsrcrecordid>eNqFkEtPwzAQhC0EoqVw5Yh845TiR2wn3EqAAqoAIR5Hy3E2YEiTNk4E_fektFTcOO1o95vRahA6pGRICWEns9qaISNEEqIU3UJ9GkkWRFyE2xsdyh7a8_6dEBEyRXZRj1HKpZRhHz0nhSudNQWe1VUD1dRZf4pHuATIcFPhDHJXAm7eAOcOigyb8mefwqsrl8JDg00G89Y0gH3TnU2d-X20k5vCw8F6DtDT5cVjchVM7sbXyWgS2JAxGliQOQXFaayoAksjBQqMydOUx0ooziMBShApDc9yYRi3wuTAGUAq4lgYPkDHq9zu-3kLvtFT5y0UhSmhar2OqBQsCqOwI4cr0taV9zXkela7qakXmhK9rFIvq9SbKjvD0Tq6TaeQbfDf7jogXgGfroDFP3H6_iEZ_Q0PVl7nG_jaeE39oaXiSuiX27E-Tyi5ic6oTvg3KPqOtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>816528484</pqid></control><display><type>article</type><title>Clinical proteomics: A need to define the field and to begin to set adequate standards</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Mischak, Harald ; Apweiler, Rolf ; Banks, Rosamonde E. ; Conaway, Mark ; Coon, Joshua ; Dominiczak, Anna ; Ehrich, Jochen H. H. ; Fliser, Danilo ; Girolami, Mark ; Hermjakob, Henning ; Hochstrasser, Denis ; Jankowski, Joachim ; Julian, Bruce A. ; Kolch, Walter ; Massy, Ziad A. ; Neusuess, Christian ; Novak, Jan ; Peter, Karlheinz ; Rossing, Kasper ; Schanstra, Joost ; Semmes, O. John ; Theodorescu, Dan ; Thongboonkerd, Visith ; Weissinger, Eva M. ; Van Eyk, Jennifer E. ; Yamamoto, Tadashi</creator><creatorcontrib>Mischak, Harald ; Apweiler, Rolf ; Banks, Rosamonde E. ; Conaway, Mark ; Coon, Joshua ; Dominiczak, Anna ; Ehrich, Jochen H. H. ; Fliser, Danilo ; Girolami, Mark ; Hermjakob, Henning ; Hochstrasser, Denis ; Jankowski, Joachim ; Julian, Bruce A. ; Kolch, Walter ; Massy, Ziad A. ; Neusuess, Christian ; Novak, Jan ; Peter, Karlheinz ; Rossing, Kasper ; Schanstra, Joost ; Semmes, O. John ; Theodorescu, Dan ; Thongboonkerd, Visith ; Weissinger, Eva M. ; Van Eyk, Jennifer E. ; Yamamoto, Tadashi</creatorcontrib><description>The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. Our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state‐of‐the‐art, both in diagnosis and in therapy of diseases.</description><identifier>ISSN: 1862-8346</identifier><identifier>EISSN: 1862-8354</identifier><identifier>DOI: 10.1002/prca.200600771</identifier><identifier>PMID: 21136664</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Biomarker ; Clinical diagnostics ; Protein marker discovery ; Protein profiling ; Proteome analysis</subject><ispartof>Proteomics. Clinical applications, 2007-02, Vol.1 (2), p.148-156</ispartof><rights>Copyright © 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>Copyright © 2007 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3</citedby><cites>FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21136664$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mischak, Harald</creatorcontrib><creatorcontrib>Apweiler, Rolf</creatorcontrib><creatorcontrib>Banks, Rosamonde E.</creatorcontrib><creatorcontrib>Conaway, Mark</creatorcontrib><creatorcontrib>Coon, Joshua</creatorcontrib><creatorcontrib>Dominiczak, Anna</creatorcontrib><creatorcontrib>Ehrich, Jochen H. H.</creatorcontrib><creatorcontrib>Fliser, Danilo</creatorcontrib><creatorcontrib>Girolami, Mark</creatorcontrib><creatorcontrib>Hermjakob, Henning</creatorcontrib><creatorcontrib>Hochstrasser, Denis</creatorcontrib><creatorcontrib>Jankowski, Joachim</creatorcontrib><creatorcontrib>Julian, Bruce A.</creatorcontrib><creatorcontrib>Kolch, Walter</creatorcontrib><creatorcontrib>Massy, Ziad A.</creatorcontrib><creatorcontrib>Neusuess, Christian</creatorcontrib><creatorcontrib>Novak, Jan</creatorcontrib><creatorcontrib>Peter, Karlheinz</creatorcontrib><creatorcontrib>Rossing, Kasper</creatorcontrib><creatorcontrib>Schanstra, Joost</creatorcontrib><creatorcontrib>Semmes, O. John</creatorcontrib><creatorcontrib>Theodorescu, Dan</creatorcontrib><creatorcontrib>Thongboonkerd, Visith</creatorcontrib><creatorcontrib>Weissinger, Eva M.</creatorcontrib><creatorcontrib>Van Eyk, Jennifer E.</creatorcontrib><creatorcontrib>Yamamoto, Tadashi</creatorcontrib><title>Clinical proteomics: A need to define the field and to begin to set adequate standards</title><title>Proteomics. Clinical applications</title><addtitle>Prot. Clin. Appl</addtitle><description>The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. Our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state‐of‐the‐art, both in diagnosis and in therapy of diseases.</description><subject>Biomarker</subject><subject>Clinical diagnostics</subject><subject>Protein marker discovery</subject><subject>Protein profiling</subject><subject>Proteome analysis</subject><issn>1862-8346</issn><issn>1862-8354</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkEtPwzAQhC0EoqVw5Yh845TiR2wn3EqAAqoAIR5Hy3E2YEiTNk4E_fektFTcOO1o95vRahA6pGRICWEns9qaISNEEqIU3UJ9GkkWRFyE2xsdyh7a8_6dEBEyRXZRj1HKpZRhHz0nhSudNQWe1VUD1dRZf4pHuATIcFPhDHJXAm7eAOcOigyb8mefwqsrl8JDg00G89Y0gH3TnU2d-X20k5vCw8F6DtDT5cVjchVM7sbXyWgS2JAxGliQOQXFaayoAksjBQqMydOUx0ooziMBShApDc9yYRi3wuTAGUAq4lgYPkDHq9zu-3kLvtFT5y0UhSmhar2OqBQsCqOwI4cr0taV9zXkela7qakXmhK9rFIvq9SbKjvD0Tq6TaeQbfDf7jogXgGfroDFP3H6_iEZ_Q0PVl7nG_jaeE39oaXiSuiX27E-Tyi5ic6oTvg3KPqOtA</recordid><startdate>20070201</startdate><enddate>20070201</enddate><creator>Mischak, Harald</creator><creator>Apweiler, Rolf</creator><creator>Banks, Rosamonde E.</creator><creator>Conaway, Mark</creator><creator>Coon, Joshua</creator><creator>Dominiczak, Anna</creator><creator>Ehrich, Jochen H. H.</creator><creator>Fliser, Danilo</creator><creator>Girolami, Mark</creator><creator>Hermjakob, Henning</creator><creator>Hochstrasser, Denis</creator><creator>Jankowski, Joachim</creator><creator>Julian, Bruce A.</creator><creator>Kolch, Walter</creator><creator>Massy, Ziad A.</creator><creator>Neusuess, Christian</creator><creator>Novak, Jan</creator><creator>Peter, Karlheinz</creator><creator>Rossing, Kasper</creator><creator>Schanstra, Joost</creator><creator>Semmes, O. John</creator><creator>Theodorescu, Dan</creator><creator>Thongboonkerd, Visith</creator><creator>Weissinger, Eva M.</creator><creator>Van Eyk, Jennifer E.</creator><creator>Yamamoto, Tadashi</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><scope>BSCLL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070201</creationdate><title>Clinical proteomics: A need to define the field and to begin to set adequate standards</title><author>Mischak, Harald ; Apweiler, Rolf ; Banks, Rosamonde E. ; Conaway, Mark ; Coon, Joshua ; Dominiczak, Anna ; Ehrich, Jochen H. H. ; Fliser, Danilo ; Girolami, Mark ; Hermjakob, Henning ; Hochstrasser, Denis ; Jankowski, Joachim ; Julian, Bruce A. ; Kolch, Walter ; Massy, Ziad A. ; Neusuess, Christian ; Novak, Jan ; Peter, Karlheinz ; Rossing, Kasper ; Schanstra, Joost ; Semmes, O. John ; Theodorescu, Dan ; Thongboonkerd, Visith ; Weissinger, Eva M. ; Van Eyk, Jennifer E. ; Yamamoto, Tadashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biomarker</topic><topic>Clinical diagnostics</topic><topic>Protein marker discovery</topic><topic>Protein profiling</topic><topic>Proteome analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mischak, Harald</creatorcontrib><creatorcontrib>Apweiler, Rolf</creatorcontrib><creatorcontrib>Banks, Rosamonde E.</creatorcontrib><creatorcontrib>Conaway, Mark</creatorcontrib><creatorcontrib>Coon, Joshua</creatorcontrib><creatorcontrib>Dominiczak, Anna</creatorcontrib><creatorcontrib>Ehrich, Jochen H. H.</creatorcontrib><creatorcontrib>Fliser, Danilo</creatorcontrib><creatorcontrib>Girolami, Mark</creatorcontrib><creatorcontrib>Hermjakob, Henning</creatorcontrib><creatorcontrib>Hochstrasser, Denis</creatorcontrib><creatorcontrib>Jankowski, Joachim</creatorcontrib><creatorcontrib>Julian, Bruce A.</creatorcontrib><creatorcontrib>Kolch, Walter</creatorcontrib><creatorcontrib>Massy, Ziad A.</creatorcontrib><creatorcontrib>Neusuess, Christian</creatorcontrib><creatorcontrib>Novak, Jan</creatorcontrib><creatorcontrib>Peter, Karlheinz</creatorcontrib><creatorcontrib>Rossing, Kasper</creatorcontrib><creatorcontrib>Schanstra, Joost</creatorcontrib><creatorcontrib>Semmes, O. John</creatorcontrib><creatorcontrib>Theodorescu, Dan</creatorcontrib><creatorcontrib>Thongboonkerd, Visith</creatorcontrib><creatorcontrib>Weissinger, Eva M.</creatorcontrib><creatorcontrib>Van Eyk, Jennifer E.</creatorcontrib><creatorcontrib>Yamamoto, Tadashi</creatorcontrib><collection>Istex</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Proteomics. Clinical applications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mischak, Harald</au><au>Apweiler, Rolf</au><au>Banks, Rosamonde E.</au><au>Conaway, Mark</au><au>Coon, Joshua</au><au>Dominiczak, Anna</au><au>Ehrich, Jochen H. H.</au><au>Fliser, Danilo</au><au>Girolami, Mark</au><au>Hermjakob, Henning</au><au>Hochstrasser, Denis</au><au>Jankowski, Joachim</au><au>Julian, Bruce A.</au><au>Kolch, Walter</au><au>Massy, Ziad A.</au><au>Neusuess, Christian</au><au>Novak, Jan</au><au>Peter, Karlheinz</au><au>Rossing, Kasper</au><au>Schanstra, Joost</au><au>Semmes, O. John</au><au>Theodorescu, Dan</au><au>Thongboonkerd, Visith</au><au>Weissinger, Eva M.</au><au>Van Eyk, Jennifer E.</au><au>Yamamoto, Tadashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical proteomics: A need to define the field and to begin to set adequate standards</atitle><jtitle>Proteomics. Clinical applications</jtitle><addtitle>Prot. Clin. Appl</addtitle><date>2007-02-01</date><risdate>2007</risdate><volume>1</volume><issue>2</issue><spage>148</spage><epage>156</epage><pages>148-156</pages><issn>1862-8346</issn><eissn>1862-8354</eissn><abstract>The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. Our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state‐of‐the‐art, both in diagnosis and in therapy of diseases.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>21136664</pmid><doi>10.1002/prca.200600771</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1862-8346 |
ispartof | Proteomics. Clinical applications, 2007-02, Vol.1 (2), p.148-156 |
issn | 1862-8346 1862-8354 |
language | eng |
recordid | cdi_proquest_miscellaneous_816528484 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Biomarker Clinical diagnostics Protein marker discovery Protein profiling Proteome analysis |
title | Clinical proteomics: A need to define the field and to begin to set adequate standards |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A43%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20proteomics:%20A%20need%20to%20define%20the%20field%20and%20to%20begin%20to%20set%20adequate%20standards&rft.jtitle=Proteomics.%20Clinical%20applications&rft.au=Mischak,%20Harald&rft.date=2007-02-01&rft.volume=1&rft.issue=2&rft.spage=148&rft.epage=156&rft.pages=148-156&rft.issn=1862-8346&rft.eissn=1862-8354&rft_id=info:doi/10.1002/prca.200600771&rft_dat=%3Cproquest_cross%3E816528484%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4221-ce6f1e7319717ec187e7eaafbb397573385e75066a3df5a23c5afe32eeb5995a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=816528484&rft_id=info:pmid/21136664&rfr_iscdi=true |